Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)

NCT01616290 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Artery Disease

Interventions

DRUG: PRT-201

Sponsor

Proteon Therapeutics

Collaborators

[object Object]